HUMAN DEBUT In the last year, research teams have announced CRISPR gene editing in viable human embryos (single-cell embryo shown).

Claude Cortier/Science Source

CANCER CRUSH In CAR-T cell therapy, a cancer treatment approved by the FDA this year for certain blood cancers, a patient’s T cells (teal) are genetically modified to hunt down and kill cancer cells (blue).